These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8867047)
1. Arginine vasopressin release by acetylcholine or norepinephrine: region-specific and cytokine-specific regulation. Raber J; Bloom FE Neuroscience; 1996 Apr; 71(3):747-59. PubMed ID: 8867047 [TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: comparison with the hypothalamic response. Raber J; Koob GF; Bloom FE Neurochem Int; 1997; 30(4-5):455-63. PubMed ID: 9106261 [TBL] [Abstract][Full Text] [Related]
3. IL-2 induces vasopressin release from the hypothalamus and the amygdala: role of nitric oxide-mediated signaling. Raber J; Bloom FE J Neurosci; 1994 Oct; 14(10):6187-95. PubMed ID: 7523633 [TBL] [Abstract][Full Text] [Related]
4. IL-1 beta potentiates the acetylcholine-induced release of vasopressin from the hypothalamus in vitro, but not from the amygdala. Raber J; Pich EM; Koob GF; Bloom FE Neuroendocrinology; 1994 Mar; 59(3):208-17. PubMed ID: 8159270 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. Raber J; Koob GF; Bloom FE J Pharmacol Exp Ther; 1995 Feb; 272(2):815-24. PubMed ID: 7853199 [TBL] [Abstract][Full Text] [Related]
6. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro. Bridges TE; Hillhouse EW; Jones MT J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183 [TBL] [Abstract][Full Text] [Related]
7. Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. Hillhouse EW; Milton NG J Endocrinol; 1989 Sep; 122(3):719-23. PubMed ID: 2809479 [TBL] [Abstract][Full Text] [Related]
8. Transmitter mediated arginine vasopressin release from superfused hypothalamus and pituitary gland. Wagner H; Häberle H; Maier V; Lang RE J Endocrinol Invest; 1978 Jul; 1(3):215-20. PubMed ID: 41869 [TBL] [Abstract][Full Text] [Related]
9. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. Hillhouse EW; Milton NG J Endocrinol; 1989 Sep; 122(3):713-8. PubMed ID: 2572662 [TBL] [Abstract][Full Text] [Related]
10. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha. Hayley S; Staines W; Merali Z; Anisman H Neuroscience; 2001; 106(1):137-48. PubMed ID: 11564424 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus. Rettori V; Gimeno M; Lyson K; McCann SM Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11543-6. PubMed ID: 1280829 [TBL] [Abstract][Full Text] [Related]
13. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959 [TBL] [Abstract][Full Text] [Related]
14. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. Wei R; Phillips TM; Sternberg EM J Neuroimmunol; 2002 Oct; 131(1-2):31-40. PubMed ID: 12458034 [TBL] [Abstract][Full Text] [Related]
15. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease. Zelazowski P; Patchev VK; Zelazowska EB; Chrousos GP; Gold PW; Sternberg EM Brain Res; 1993 Dec; 631(1):22-6. PubMed ID: 8298992 [TBL] [Abstract][Full Text] [Related]
16. Coloboma hyperactive mutant mice exhibit regional and transmitter-specific deficits in neurotransmission. Raber J; Mehta PP; Kreifeldt M; Parsons LH; Weiss F; Bloom FE; Wilson MC J Neurochem; 1997 Jan; 68(1):176-86. PubMed ID: 8978724 [TBL] [Abstract][Full Text] [Related]
17. Effect of atrial natriuretic peptide on acetylcholine-induced release of corticotropin-releasing factor from rat hypothalamus in vitro. Takao T; Hashimoto K; Ota Z Life Sci; 1988; 42(12):1199-203. PubMed ID: 2964553 [TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Karanth S; Lyson K; McCann SM Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3383-7. PubMed ID: 8475085 [TBL] [Abstract][Full Text] [Related]
19. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone- and arginine-vasopressin-stimulated release of hypothalamic beta-endorphin. Patchev VK; Racké K; Almeida OF Neuroendocrinology; 1991 Aug; 54(2):111-7. PubMed ID: 1766548 [TBL] [Abstract][Full Text] [Related]
20. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation. Patchev VK; Karalis K; Chrousos GP Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]